- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04074642
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study. (FIRST)
November 15, 2023 updated by: Centre Hospitalier Universitaire de Nice
The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.
Study Overview
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: ARNAUD MARTEL
- Phone Number: 0492033737
- Email: martel.a@chu-nice.fr
Study Locations
-
-
-
Nice, France, 06000
- CHU de Nice
-
Nice, France, 06001
- Hôpital Pasteur 2 - Service d'Ophtalmologie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- pituitary compressive adenoma (for experimental group)
- pituitary non compressive adenoma
Exclusion Criteria:
- retinian disease
- amblyopia
- parkinson disease
- pregnant woman
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Non compressive adenoma
Optical Coherence Tomography Angiography without surgery
|
|
Experimental: Compressive adenoma
Optical Coherence Tomography Angiography before and after neurosurgery
|
adenoma removal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of middle deviation
Time Frame: before surgery (= inclusion), 4 months after surgery and 10 months after surgery
|
visual field evolution assessed by Middle deviation
|
before surgery (= inclusion), 4 months after surgery and 10 months after surgery
|
Change of visual function index
Time Frame: before surgery (= inclusion), 4 months after surgery and 10 months after surgery
|
visual field evolution assessed by visual function index
|
before surgery (= inclusion), 4 months after surgery and 10 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: ARNAUD MARTEL, ophtalmology department, Nice University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 14, 2019
Primary Completion (Actual)
February 22, 2023
Study Completion (Actual)
February 22, 2023
Study Registration Dates
First Submitted
August 20, 2019
First Submitted That Met QC Criteria
August 28, 2019
First Posted (Actual)
August 30, 2019
Study Record Updates
Last Update Posted (Estimated)
November 16, 2023
Last Update Submitted That Met QC Criteria
November 15, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Neoplasms, Glandular and Epithelial
- Eye Diseases
- Neurologic Manifestations
- Endocrine System Diseases
- Endocrine Gland Neoplasms
- Hypothalamic Diseases
- Hypothalamic Neoplasms
- Supratentorial Neoplasms
- Brain Neoplasms
- Central Nervous System Neoplasms
- Nervous System Neoplasms
- Sensation Disorders
- Pituitary Diseases
- Adenoma
- Pituitary Neoplasms
- Vision, Low
- Vision Disorders
Other Study ID Numbers
- 19-AOI-06
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pituitary Adenoma
-
Asan Medical CenterUnknownPituitary ACTH Secreting AdenomaKorea, Republic of
-
Zhaoyun ZhangUnknownPituitary TumorChina
-
Tiburio TherapeuticsNot yet recruitingNon-Functional Pituitary Adenoma | Pituitary Tumor, Nonfunctioning
-
University of CopenhagenOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsCompletedAcromegaly Due to Pituitary AdenomaDenmark
-
Samsung Medical CenterNot yet recruitingAcromegaly Due to Pituitary AdenomaKorea, Republic of
-
Vastra Gotaland RegionRecruitingNon-functioning Pituitary AdenomaSweden
-
Asan Medical CenterUnknownCavernous Sinus Invasion by Pituitary AdenomaKorea, Republic of
-
Zealand University HospitalNot yet recruitingNon-Functional Pituitary Adenoma
-
Novartis PharmaceuticalsCompleted
-
University of Sao Paulo General HospitalCompletedPituitary Adenoma | Nonfunctioning Pituitary AdenomaBrazil
Clinical Trials on Neurosurgery
-
National Institute of Mental Health and Neuro Sciences...RecruitingPostoperative Pain | NeurosurgeryIndia
-
Montefiore Medical CenterRecruitingAneurysm Cerebral (Unruptured)United States
-
Hospices Civils de LyonCompleted
-
Centre hospitalier de l'Université de Montréal...Centre Hospitalier Régional et Universitaire de BrestRecruitingArteriovenous Malformations | Unruptured Brain Arteriovenous Malformation | Ruptured Brain Arteriovenous Malformation | AVM | BAVMFrance, United States, Canada, Brazil, Chile, Colombia
-
Beijing Tiantan HospitalBeijing Friendship Hospital; Beijing Chao Yang Hospital; Beijing Anzhen Hospital and other collaboratorsRecruitingComplications | Emergency Surgery | Severe Spontaneous Intracranial Hemorrhage | Long-term Antiplatelet TreatmentChina
-
Beijing Tiantan HospitalBeijing Chao Yang Hospital; Beijing Anzhen Hospital; Guangzhou Red Cross Hospital and other collaboratorsCompletedComplications | Emergency Surgery | Severe Spontaneous Intracranial Hemorrhage | Long-term Antiplatelet TreatmentChina
-
Barretos Cancer HospitalWithdrawn
-
OHSU Knight Cancer InstituteNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...TerminatedBrain NeoplasmsUnited States
-
University of ZurichEnrolling by invitationPatients Treated at the Neurosurgery DepartmentSwitzerland
-
University Hospital, MontpellierNational Development and Research Institutes, Inc.Active, not recruiting